Quest promotes Marlborough Economic Development Corp. board member to SVP
Photo | Courtesy of Quest Diagnostics
Karthik Kuppusamy has been named senior vice president of clinical solutions at Quest Diagnostics.
Karthik Kuppusamy has been named senior vice president of clinical solutions at Quest Diagnostics in Marlborough.
Previously Kuppusamy was the general manager of Quest’s north region and, before that, he led the company’s neurology franchise and helped launch its screening and tests for dementia and Alzheimer’s disease as well as chromosomal abnormalities and neuroimmunological diseases, according to a Thursday press release from Quest.
Kuppusamy will be responsible for bringing innovative diagnostic solutions to market through Quest's clinical franchises as well as pharma services, genomic services, and global markets.
Kuppusamy takes over for Cathy Doherty, who was in charge of general diagnostics. Doherty is now in charge of regional businesses. Kuppusamy has taken on some of Doherty’s previous responsibilities as well some of those from Carrie Eglinton Manner, who was Quest’s senior vice president for advanced diagnostics. Eglinton Manner left Quest in June to become CEO of OraSure Technologies in Pennsylvania.
Kuppusamy is on the board of directors for the Marlborough Economic Development Corp.. He has a bachelor’s degree in electronics and communications engineering from Anna University in India and a master’s degree in biomedical engineering from the Indian Institute of Technology. He has an MBA in finance and operations from Marquette University in Wisconsin and a PhD in electrical and biomedical engineering from Washington University in St. Louis.
Quest also announced Thursday that Mark Gardner has been appointed to the newly created position of senior vice president, molecular genomics and oncology, and Kristin Wallace is now senior vice president of compliance. She succeeds Tim Sharpe, who retired in August. Neither Gardner nor Wallace will be based in Marlborough.
WBJ Web Partners
Most Recent
Most Recent
0 Comments